Table 3 Neonatal morbidities of the weighted population.
Variables | Non-EHMD (n = 1015)b | EHMD (n = 805)b | p valuea |
|---|---|---|---|
Intraventricular hemorrhage, n (%) | |||
Any grade | 199 (19.6) | 251 (31.2) | 0.001 |
Grade 3/4 | 50 (4.9) | 56 (6.9) | 0.211 |
Indomethacin/ibuprofen treated, n (%) | 65 (6.4) | 108 (13.5) | <0.001 |
Necrotizing enterocolitis, n (%) | 7 (0.7) | 10 (1.2) | 0.361 |
Spontaneous intestinal perforation, n (%) | 20 (2.0) | 12 (1.4) | 0.569 |
Total days of IV antibiotics (day), mean [IQR] | 3 [3, 8] | 3 [2, 7] | 0.587 |
Bronchopulmonary dysplasia, n (%) | 0.193 | ||
No | 764 (75.3) | 589 (73.3) | |
Grade 1 | 150 (14.8) | 98 (12.1) | |
Grade 2 | 90 (8.8) | 106 (13.1) | |
Grade 3 | 11 (1.1) | 12 (1.5) | |
Grade 2/3 bronchopulmonary dysplasia, n (%) | 101 (9.9) | 118 (14.6) | 0.039 |
Postnatal corticosteroids, n (%) | 19 (1.8) | 44 (5.5) | 0.001 |
Retinopathy of prematurity ≥ stage 2, n (%) | 151 (14.9) | 100 (12.4) | 0.309 |
Periventricular leukomalacia, n (%) | 17 (1.7) | 13 (1.6) | 0.923 |
Hypotonia (M69.2), n (%) | 33 (3.3) | 24 (3.0) | 0.836 |
Cerebral palsy (G80.X), n (%) | 29 (2.9) | 25 (3.1) | 0.848 |
Specific developmental disorder of motor function (F82), n (%) | 200 (19.7) | 128 (15.9) | 0.237 |
Any motor function impairment, n (%) | 211 (20.8) | 151 (18.8) | 0.539 |
